Cooper C. Collins, Chief Strategic Officer, 10% Owner at PERNIX THERAPEUTICS HOLDINGS, INC. (PTX), sold 90,000 shares at $2.56 ($200K) on 2014-02-05, disclosed to the SEC on 2014-02-05.
Scheduled sale ($200k) by Chief Strategic Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.16 | 32,700 | $71K | 35.3% |
| 2 | $2.11 | 42,500 | $90K | 44.9% |
| 3 | $2.56 | 13,070 | $33K | 16.7% |
| 4 | $3.53 | 1,730 | $6K | 3.1% |
| Total | $2.22 avg | 90,000 | $200K | 100% |
| Filing → |
| TXMD | BUY | 2021-11-22 | $580K | — | Filing → |
| TXMD | BUY | 2021-08-19 | $725K | — | Filing → |
| TXMD | BUY | 2020-06-10 | $107K | — | Filing → |